logo
Twitter
Discord
Email
logo
Semler Scientific, Inc.

Semler Scientific, Inc.

NASDAQ•SMLR
CEO: Dr. Douglas Murphy-Chutorian M.D.
Sector: Healthcare
Industry: Medical - Devices
Listing Date: 2014-02-21
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
Contact Information
2340-2348 Walsh Avenue, Suite 2344, Santa Clara, CA, 95051, United States
877-774-4211
www.semlerscientific.com
Market Cap
$404.90M
P/E (TTM)
8.9
vs Industry 42.6
Dividend Yield (TTM)
--
52W High
$81.56
52W Low
$21.84
52W Range
9%
4.5
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4.5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q2 2025 Data

Revenue

$8.22M-43.19%
4-Quarter Trend

EPS

$5.71+356775.00%
4-Quarter Trend

FCF

$446.00K-100.81%
4-Quarter Trend

Earnings Highlights

Key Highlights

No Data Available

Risk Factors

No Data Available

Outlook

No Data Available

Peer Comparison

Revenue (TTM)

Owens & Minor, Inc.OMI
$8.73B
-17.1%
The Oncology Institute, Inc.TOI
$424.38M
+17.5%
Tactile Systems Technology, Inc.TCMD
$298.85M
+6.1%

Gross Margin (Latest Quarter)

Semler Scientific, Inc.SMLR
91.0%
-0.3 pp
Delcath Systems, Inc.DCTH
86.3%
+5.8 pp
Treace Medical Concepts, Inc.TMCI
79.7%
-0.6 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
TOI$437.08M-67.3-1739.1%64.6%
TMCI$425.16M-8.8-46.8%34.0%
OMI$418.28M-0.3-278.2%11.2%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
-15.3%
Growth Under Pressure
4-Quarter Net Income CAGR
+128.5%
Significant Improvement in Profitability
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Reports
All Years
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 4, 2025|
    Revenue: $8.22M-43.2%
    |
    EPS: $5.71+356775.0%
    Beat
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 13, 2025|
    Revenue: $8.84M-44.4%
    |
    EPS: $-6.74-865.9%
    N/A
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 28, 2025|
    Revenue: $56.29M-17.4%
    |
    EPS: $5.66+85.0%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 5, 2024|
    Revenue: $13.51M-17.2%
    |
    EPS: $0.80-2.4%
    Beat
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 6, 2024|
    Revenue: $14.47M-22.3%
    |
    EPS: $0.00-99.8%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 8, 2024|
    Revenue: $15.90M-12.7%
    |
    EPS: $0.88+18.9%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Mar 7, 2024|
    Revenue: $68.18M+20.3%
    |
    EPS: $3.06+43.7%
    Beat
  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Nov 13, 2023|
    Revenue: $16.32M+16.2%
    |
    EPS: $0.82+49.1%
    Beat